ARCHIVES

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

This article is from The Cancer Letter archive.

Vol. 11 No. 32 | August 9, 1985

Download PDF Visit The Full Archive

Related Articles

Appropriations Committees Lean Toward Adding Some To NCI Budget; ACS To Ask Again For $1.5 Billion

April 20, 1984

Seer Gets Concept Approval For Three More Years, With Several Changes

June 19, 1981

Tracor Could Earn $186,000 As Prime Contractor On Carcinogenesis Bioassay

April 26, 1974

Recurrent Low-Grade Serous Carcinoma Less Responsive To Chemotherapy

March 28, 2008

Judge Hears Arguments In Fisher’s Privacy Act Suit Over Databases

January 19, 1996

For R01s, 195 or P01s Center Funds Up By $600,000

May 22, 1981